Hot Watch List: Avalanche Biotechnologies, Inc. (NASDAQ:AAVL), Celldex Therapeutics, Inc. (NASDAQ:CLDX), Uranium Energy Corp. (NYSEMKT:UEC), Zhaopin Ltd. (NYSE:ZPIN), Con-way Inc. (NYSE:CNW)

Avalanche Biotechnologies, Inc. (NASDAQ:AAVL) belongs to Healthcare sector. Its weekly performance is 2.33%. On last trading day company shares ended up $39.13. Avalanche Biotechnologies, Inc. (NASDAQ:AAVL) distance from 50-day simple moving average (SMA50) is 2.69%. Jefferies Group reiterated their buy rating on shares of Avalanche Biotechnologies, Inc. (NASDAQ:AAVL) in a research report released on Saturday morning. Jefferies Group currently has a $51.00 price objective on the stock.

Celldex Therapeutics, Inc. (NASDAQ:CLDX) shares increased 2.15% in last trading session and ended the day at $28.47. CLDX return on assets is -48.40%. Celldex Therapeutics, Inc. (NASDAQ:CLDX) quarterly performance is 14.06%.Celldex Therapeutics, Inc. (NASDAQ:CLDX) announced that Anthony Marucci, Co-founder, President and Chief Executive Officer, will present a corporate overview at the Jefferies 2015 Global Healthcare Conference on June 3, 2015 at 3:30 p.m. EDT in New York City

On 27 May, Uranium Energy Corp. (NYSEMKT:UEC) shares increased 3.45% and was closed at $2.70. UEC EPS growth in last 5 year was -1.40%. Uranium Energy Corp. (NYSEMKT:UEC) year to date (YTD) performance is 54.29%. Uranium Energy Corp. (NYSEMKT:UEC) announced that it had received all required permits to produce uranium from new resource areas at the Palangana in situ recovery (ISR) mine, in Texas, after it had obtained a larger mine permit and aquifer exemption from state authorities.

Zhaopin Ltd. (NYSE:ZPIN) ended the last trading day at $16.23. Company weekly volatility is calculated as 4.82% and price to cash ratio as 3.98. Zhaopin Ltd. (NYSE:ZPIN) showed a weekly performance of 8.42%. On 26 May, Zhaopin Ltd. (NYSE:ZPIN) announced its unaudited financial results for the third quarter ended March 31, 2015. Total revenues increased 18.1% to RMB317.5 million (US$51.2 million), exceeding the upper end of the Company’s revenue guidance by RMB2.5 million (US$0.4 million).

Con-way Inc. (NYSE:CNW) shares increased 1.81% in last trading session and ended the day at $42.10. CNW Gross Margin is 64.60% and its return on assets is 4.30%. Con-way Inc. (NYSE:CNW) quarterly performance is -6.71%. Con-way Inc. (NYSE:CNW) declared a cash dividend of 15 cents per share on the company’s common stock. The dividend is payable on June 12, 2015 to shareholders of record on May 15, 2015.

Leave a Reply

Your email address will not be published. Required fields are marked *